| | | 60057 | | 10.06.2010 | | Boehringer Ingelheim (Schweiz) GmbH | | | | | | | | | | | | | 01.08. | | | | 01.08. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Sifrol ER 0,375 mg | Retardtabletten | Delayed release tablets (Pramipexol Dihydrochloride Monohydrate 0.375 mg) | N04BC05 | CI | | 02 | Sifrol ER 0,75 mg | Retardtabletten | Delayed release tablets (Pramipexol Dihydrochloride Monohydrate 0.75 mg) | N04BC05 | CI | | 03 | Sifrol ER 1,5 mg | Retardtabletten | Delayed release tablets (Pramipexol Dihydrochloride Monohydrate 1.5 mg) | N04BC05 | CI | | 04 | Sifrol ER 3,0 mg | Retardtabletten | Delayed release tablets (Pramipexol Dihydrochloride Monohydrate 3 mg) | N04BC05 | CI | | 05 | Sifrol ER 4,5 mg | Retardtabletten | Delayed release tablets (Pramipexol Dihydrochloride Monohydrate 4.5 mg) | N04BC05 | CI |
|
|
